Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Lichtenfels

3 clinical trials in Lichtenfels, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Lichtenfels at a glance
3
clinical trials
  • Recruiting now0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

3 trials in Lichtenfels

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:INSULIN DEGLUDEC
  • Sponsor:Novo Nordisk A/S
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Novartis Pharma GmbH

Hypercholesterolaemia

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Inclisiran
  • Sponsor:Novartis Pharma AG

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Lichtenfels

What the registry says about research in the country

01 Cardiovascular Research

Groundbreaking studies focusing on Type 2 Diabetes Mellitus and cardiovascular outcomes, comparing innovative treatments to evaluate their effectiveness in reducing major cardiovascular events.

  • Diabetes Management
  • Cardiovascular Risk Prevention
  • Treatment Comparison Studies

Research aims to enhance understanding of cardiovascular protection in diabetic patients using advanced therapeutic approaches.

02 Lipid Management Studies

Innovative research examining Hypercholesterolemia treatments, with particular focus on novel approaches to lowering LDL cholesterol levels in patients on existing lipid-lowering therapies.

  • Cholesterol Management
  • Quality of Life Assessment
  • Combination Therapy Evaluation

These trials explore the effectiveness of new therapeutic options for patients with challenging cholesterol management needs.

03 Cardiovascular Disease Management

Advanced clinical investigations in atherosclerotic cardiovascular disease, comparing different therapeutic approaches for optimal cholesterol control in high-risk patients.

  • Comparative Treatment Studies
  • Standard of Care Enhancement
  • LDL-C Reduction Strategies

Research focuses on determining the most effective treatment combinations for managing cardiovascular risk factors.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.